These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32590296)

  • 1. Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer.
    Mastelic-Gavillet B; Sarivalasis A; Lozano LE; Wyss T; Inoges S; de Vries IJM; Dartiguenave F; Jichlinski P; Derrè L; Coukos G; Melero I; Harari A; Romero P; Viganó S; Kandalaft LE
    Eur J Cancer; 2020 Aug; 135():173-182. PubMed ID: 32590296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased tubulointerstitial recruitment of human CD141(hi) CLEC9A(+) and CD1c(+) myeloid dendritic cell subsets in renal fibrosis and chronic kidney disease.
    Kassianos AJ; Wang X; Sampangi S; Muczynski K; Healy H; Wilkinson R
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1391-401. PubMed ID: 24049150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD141⁺ myeloid dendritic cells are enriched in healthy human liver.
    Kelly A; Fahey R; Fletcher JM; Keogh C; Carroll AG; Siddachari R; Geoghegan J; Hegarty JE; Ryan EJ; O'Farrelly C
    J Hepatol; 2014 Jan; 60(1):135-42. PubMed ID: 23968887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141
    Masterman KA; Haigh OL; Tullett KM; Leal-Rojas IM; Walpole C; Pearson FE; Cebon J; Schmidt C; O'Brien L; Rosendahl N; Daraj G; Caminschi I; Gschweng EH; Hollis RP; Kohn DB; Lahoud MH; Radford KJ
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32737142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human CD141
    Lee YS; O'Brien LJ; Walpole CM; Pearson FE; Leal-Rojas IM; Masterman KA; Atkinson V; Barbour A; Radford KJ
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FLT3-ligand treatment of humanized mice results in the generation of large numbers of CD141+ and CD1c+ dendritic cells in vivo.
    Ding Y; Wilkinson A; Idris A; Fancke B; O'Keeffe M; Khalil D; Ju X; Lahoud MH; Caminschi I; Shortman K; Rodwell R; Vuckovic S; Radford KJ
    J Immunol; 2014 Feb; 192(4):1982-9. PubMed ID: 24453245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.
    Jongbloed SL; Kassianos AJ; McDonald KJ; Clark GJ; Ju X; Angel CE; Chen CJ; Dunbar PR; Wadley RB; Jeet V; Vulink AJ; Hart DN; Radford KJ
    J Exp Med; 2010 Jun; 207(6):1247-60. PubMed ID: 20479116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Superior Ability of Human BDCA3
    Gu FF; Zhang K; Ma LL; Liu YY; Li C; Hu Y; Yang QF; Liang JY; Zeng YL; Wang Y; Liu L
    Front Immunol; 2020; 11():1267. PubMed ID: 32655564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Generation of Human XCR1(+) Dendritic Cells from CD34(+) Hematopoietic Progenitors.
    Balan S; Dalod M
    Methods Mol Biol; 2016; 1423():19-37. PubMed ID: 27142006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid Arthritis.
    Cooles FAH; Anderson AE; Skelton A; Pratt AG; Kurowska-Stolarska MS; McInnes I; Hilkens CMU; Isaacs JD
    Front Immunol; 2018; 9():755. PubMed ID: 29867920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The In Vitro Differentiation of Human CD141+CLEC9A+ Dendritic Cells from Mobilized Peripheral Blood CD34+ Hematopoietic Stem Cells.
    Swartz AM; Nair SK
    Curr Protoc; 2022 Apr; 2(4):e410. PubMed ID: 35435334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal analysis of DC subsets in patients with ovarian cancer: Implications for immunotherapy.
    Mastelic-Gavillet B; Sarivalasis A; Lozano LE; Lofek S; Wyss T; Melero I; de Vries IJM; Harari A; Romero P; Kandalaft LE; Viganó S
    Front Immunol; 2023; 14():1119371. PubMed ID: 36845155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute aerobic exercise induces a preferential mobilisation of plasmacytoid dendritic cells into the peripheral blood in man.
    Brown FF; Campbell JP; Wadley AJ; Fisher JP; Aldred S; Turner JE
    Physiol Behav; 2018 Oct; 194():191-198. PubMed ID: 29763678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human blood mDC subsets exhibit distinct TLR repertoire and responsiveness.
    Hémont C; Neel A; Heslan M; Braudeau C; Josien R
    J Leukoc Biol; 2013 Apr; 93(4):599-609. PubMed ID: 23341538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A
    Koster BD; López González M; van den Hout MF; Turksma AW; Sluijter BJ; Molenkamp BG; van Leeuwen PA; Vosslamber S; Scheper RJ; van den Eertwegh AJ; van den Tol MP; Jordanova EJ; de Gruijl TD
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fully closed and automated enrichment of primary blood dendritic cells for cancer immunotherapy.
    Schreibelt G; Duiveman-de Boer T; Pots JM; van Oorschot TGM; de Boer AJ; Scharenborg NM; van de Rakt MWMM; Bos K; de Goede AL; Petry K; Brüning M; Angerer C; Schöggl C; Dzionek A; de Vries IJM
    Methods Cell Biol; 2024; 183():33-50. PubMed ID: 38548417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLEC10A Is a Specific Marker for Human CD1c
    Heger L; Balk S; Lühr JJ; Heidkamp GF; Lehmann CHK; Hatscher L; Purbojo A; Hartmann A; Garcia-Martin F; Nishimura SI; Cesnjevar R; Nimmerjahn F; Dudziak D
    Front Immunol; 2018; 9():744. PubMed ID: 29755453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells.
    He M; Soni B; Schwalie PC; Hüsser T; Waltzinger C; De Silva D; Prinz Y; Krümpelmann L; Calabro S; Matos I; Trumpfheller C; Bacac M; Umaña P; Levesque MP; Dummer R; van den Broek M; Gasser S
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35688559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human CD141
    Pearson FE; Chang K; Minoda Y; Rojas IML; Haigh OL; Daraj G; Tullett KM; Radford KJ
    Immunol Cell Biol; 2018 Apr; 96(4):390-400. PubMed ID: 29344995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling.
    Makino K; Long MD; Kajihara R; Matsueda S; Oba T; Kanehira K; Liu S; Ito F
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35101945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.